A Study to Evaluate Community-Based Measures to Increase RSV Vaccine Use Among Latino Adults

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of California, San Francisco

About this trial

In collaboration with community-based organizations, this study will focus on increasing RSV vaccine use among Latinos. The study will determine how effective community health worker counseling and text-message approaches are to (1) increase RSV vaccine use among older adults (Motivate phase) and (2) encourage younger adults to discuss RSV vaccination with their older friends and family members (Activate phase).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Age 50 years or older

Self-identify as Latino/a/x and/or indigenous groups from Latin America

Eligible for RSV vaccination per current CDC/ACIP recommendations

Fluent in Spanish or English

Disqualifiers

Intent to move outside of San Francisco or Daly City in the next year

Nursing home resident

Household member participating in Aim 1 or 2

Unable to provide consent

Trial design

Design model

Parallel

Treatments tested in this trial

  • Motivate Aim: CHW text message reminders and counseling

    Behavioral

    Participants receive both text message reminders and a counseling session, along with information about RSV and the vaccine, to encourage RSV vaccine uptake.

  • Motivate Aim: CHW text message reminders only

    Behavioral

    Participants receive text message reminders along with information about RSV and the RSV vaccine to encourage vaccine uptake, but do not receive the counseling intervention

  • Activate Aim: CHW text message reminders and counseling

    Behavioral

    Participants receive both text message reminders and a counseling session, along with information about RSV and the vaccine, to encourage discussion of RSV vaccine uptake among older adults in their social networks

  • Activate Aim: CHW text message reminders only

    Behavioral

    Participants receive text message reminders along with information about RSV and the vaccine to encourage discussion of RSV vaccine uptake among older adults in their social networks, but do not receive the counseling intervention

Treatment groups

750 Participants
are divided into 4 treatment groups
Group A: Motivate Aim: CHW text message reminders and counselingExperimental treatment 1 intervention
Group B: Motivate Aim: CHW text message reminders onlyActive comparator 1 intervention
Group C: Activate Aim: CHW text message reminders and counselingExperimental treatment 1 intervention
Group D: Activate Aim: CHW text message reminders onlyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Motivate Aim Primary Outcome - RSV Vaccine Uptake

RSV vaccine uptake at 60 days per California Immunization Registry (CAIR) or per medical record

Time frame
60 days from study enrollment
2

Activate Aim Primary Outcome - Proportion of Contacts with whom RSV Vaccination Discussed

Self-reported average proportion of social network contacts 50 years or older with whom participant discussed RSV vaccination at 60 days

Time frame
60 days after study enrollment

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of California, San Francisco

Lead sponsor

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborator

Mission Language Vocational School

Collaborator